Seite auswählen

Monoclonal antibody with new indication

People who are overweight or even obese have a greater risk of developing type 2 diabetes. Weight reduction could even prevent diabetes. This is where the Phase II study by Novartis and another team of researchers comes in: a drug originally used for pathological...